v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Schedule Components of loss before income taxes and the provision for income taxes

The components of loss before income taxes and the income tax (expense) benefit for the years ended December 31, 2023, 2022, and 2021, by jurisdiction, are as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

2023

​

2022

​

2021

​

    

U.S.

    

Foreign

    

Total

    

U.S.

    

Foreign

    

Total

    

U.S.

    

Foreign

    

Total

Loss before income taxes

 

$

(1,211,796)

​

$

(164,401)

 

$

(1,376,197)

 

$

(697,342)

 

$

(25,827)

 

$

(723,169)

 

$

(466,825)

 

$

(9,337)

 

$

(476,162)

Income tax (expense) benefit

​

​

29

​

​

7,335

​

​

7,364

​

​

868

​

​

(1,707)

​

​

(839)

​

​

16,540

​

​

(343)

​

​

16,197

Net loss

 

$

(1,211,767)

 

$

(157,066)

 

$

(1,368,833)

 

$

(696,474)

 

$

(27,534)

 

$

(724,008)

 

$

(450,285)

 

$

(9,680)

 

$

(459,965)

Schedule of Significant Components of Deferred Income Tax Expense (Benefit)

The significant components of current and deferred income tax expense (benefit) for the years ended December 31, 2023, 2022, and 2021, by jurisdiction, are as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

2023

​

2022

​

2021

​

    

U.S.

    

Foreign

    

Total

    

U.S.

    

Foreign

​

Total

    

U.S.

    

Foreign

    

Total

Current income tax (benefit) expense

​

$

—

​

$

1,170

​

$

1,170

​

$

—

​

$

668

​

$

668

​

$

—

​

$

—

​

$

—

Deferred tax (benefit) expense

​

​

(100,754)

​

​

(2,618)

​

​

(103,372)

​

​

(42,705)

​

​

6,968

​

​

(35,737)

​

​

(51,999)

​

​

1,064

​

​

(50,935)

Net operating loss carryforward generated

​

​

(146,174)

​

​

(17,653)

​

​

(163,827)

​

​

(92,030)

​

​

4,332

​

​

(87,698)

​

​

(105,498)

​

​

(2,038)

​

​

(107,536)

Valuation allowance increase (decrease)

​

​

246,899

​

​

11,766

​

​

258,665

​

​

133,867

​

​

(10,261)

​

​

123,606

​

​

140,957

​

​

1,317

​

​

142,274

Expense (benefit) for income taxes

​

$

(29)

​

​

(7,335)

​

$

(7,364)

​

$

(868)

​

$

1,707

​

$

839

​

$

(16,540)

​

$

343

​

$

(16,197)

Schedule of Effective Income Tax Rate Reconciliation

​

​

​

​

​

​

​

​

​

​

    

2023

    

2022

    

2021

 

U.S. Federal statutory tax rate

​

(21.0)

%  

(21.0)

%  

(21.0)

%  

Deferred state taxes

​

0.0

%  

0.0

%  

(0.6)

%  

Common stock warrant liability

​

0.0

%  

0.0

%  

(6.0)

%  

Section 162M Disallowance

​

0.7

%  

1.9

%  

1.1

%  

Equity Compensation

​

0.4

%  

(0.7)

%  

(4.3)

%  

Provision to return and deferred tax asset adjustments

​

(2.1)

%  

4.6

%  

(1.3)

%

Change in U.S. Federal/Foreign statutory tax rate

​

(0.1)

%  

0.0

%  

0.3

%

Other, net

​

0.6

%  

0.6

%  

(1.5)

%

Impairment of goodwill

​

3.3

%  

0.0

%  

0.0

%

Change in valuation allowance

​

17.7

%  

14.8

%  

29.9

%

​

​

(0.5)

%

0.1

%  

(3.4)

%

Schedule of Deferred Tax Assets and Liabilities The Company has recorded a net deferred tax liability in other non-current liabilities, at December 31, 2023 and 2022 of approximately $3.2 million and $11.5 million, respectively. Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2023 and 2022 are as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

U.S.

​

Foreign

​

Total

​

​

2023

​

2022

​

2023

​

2022

​

2023

​

2022

Deferred revenue

​

​

39,241

​

​

33,172

​

​

142

​

​

137

​

​

39,383

​

​

33,309

Interest expense

​

​

28,126

​

​

31,368

​

​

—

​

​

—

​

​

28,126

​

​

31,368

Other reserves and accruals

​

​

57,265

​

​

26,591

​

​

337

​

​

287

​

​

57,602

​

​

26,878

Tax credit carryforwards

​

​

20,794

​

​

14,949

​

​

—

​

​

—

​

​

20,794

​

​

14,949

Amortization of stock-based compensation

​

​

44,023

​

​

30,217

​

​

—

​

​

—

​

​

44,023

​

​

30,217

Non-compensatory warrants

​

​

2,950

​

​

6,268

​

​

—

​

​

—

​

​

2,950

​

​

6,268

Capitalized research & development expenditures

​

​

82,374

​

​

60,588

​

​

—

​

​

—

​

​

82,374

​

​

60,588

Right of use liability (operating leases)

​

​

41,960

​

​

32,616

​

​

—

​

​

259

​

​

41,960

​

​

32,875

Capital loss carryforwards

​

​

1,763

​

​

—

​

​

—

​

​

—

​

​

1,763

​

​

—

Net operating loss carryforwards

​

​

443,964

​

​

297,790

​

​

25,373

​

​

7,720

​

​

469,337

​

​

305,510

Total deferred tax asset

​

​

762,460

​

​

533,559

​

​

25,852

​

​

8,403

​

​

788,312

​

​

541,962

Valuation allowance

​

​

(676,190)

​

​

(429,291)

​

​

(19,949)

​

​

(8,183)

​

​

(696,139)

​

​

(437,474)

Net deferred tax assets

​

$

86,270

​

$

104,268

​

$

5,903

​

$

220

​

$

92,173

​

$

104,488

Intangible assets

​

​

(27,749)

​

​

(29,731)

​

​

(9,088)

​

​

(9,938)

​

​

(36,837)

​

​

(39,669)

Convertible debt

​

​

—

​

​

(26,989)

​

​

—

​

​

—

​

​

—

​

​

(26,989)

Right of use asset (operating leases)

​

​

(50,632)

​

​

(40,194)

​

​

—

​

​

(260)

​

​

(50,632)

​

​

(40,454)

Property, plant and equipment and right of use assets

​

​

(7,889)

​

​

(7,383)

​

​

—

​

​

(1,500)

​

​

(7,889)

​

​

(8,883)

Deferred tax liability

​

$

(86,270)

​

$

(104,297)

​

$

(9,088)

​

$

(11,699)

​

$

(95,358)

​

$

(115,996)

Net

​

$

—

​

$

(29)

​

$

(3,185)

​

$

(11,479)

​

$

(3,185)

​

$

(11,508)

Schedule of Valuation Allowance A reconciliation of the current year change in valuation allowance is as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

    

U.S.

    

Foreign

    

Total

Increase in valuation allowance for current year increase in net operating losses

​

$

177,299

​

​

11,496

​

$

188,795

Increase in valuation allowance for current year net increase in deferred tax assets other than net operating losses

​

​

69,600

​

​

—

​

​

69,600

Increase in valuation allowance due to change in tax rates

​

​

—

​

​

270

​

​

270

Net increase in valuation allowance

​

$

246,899

​

$

11,766

​

$

258,665